Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Navega Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Navega Therapeutics

Navega Therapeutics

Pre-Seed

Navega Therapeutics: Innovating non-addictive, specific, long-lasting, non-permanent gene therapy for pain.

HQ
San Diego, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize pain management, Navega Therapeutics is pioneering non-addictive, highly specific, and long-lasting gene therapies. The company leverages advanced zinc-finger and CRISPR-based epigenome regulation technologies to develop non-permanent gene therapies that target pain. Navega Therapeutics aims to provide innovative solutions that address the opioid crisis by offering safer alternatives for chronic pain sufferers.

Navega Therapeutics has garnered attention for its cutting-edge approach and has attracted notable investors and advisors in the biotech industry. The company's achievements include securing patents for its novel gene therapy techniques and advancing preclinical studies that demonstrate the efficacy and safety of their treatments. Navega Therapeutics is poised to make a significant impact on the field of pain management and the broader healthcare landscape by providing groundbreaking alternatives to traditional pain relief methods.

Navega Therapeutics - Similar Companies

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

Regenxbio logo

Regenxbio

regenxbio.com

Regel Therapeutics logo

Regel Therapeutics

Opsin Biotherapeutics logo

Opsin Biotherapeutics

opsinbio.com

NabGen logo

NabGen

nabgen.com

Intergalactic Therapeutics logo

Intergalactic Therapeutics

Enavate Sciences logo

Enavate Sciences

Navigen logo

Navigen

Neurocarrus logo

Neurocarrus

neurocarrus.com

Code Biotherapeutics logo

Code Biotherapeutics

codebiotx.com

Nvelop Therapeutics logo

Nvelop Therapeutics

Kriya Therapeutics logo

Kriya Therapeutics

Regulonix Holding logo

Regulonix Holding

Cargene logo

Cargene

cargene.com

Nephrogen logo

Nephrogen

Navega Therapeutics - Quick Facts

Who are Navega Therapeutics' competitors?

Companies similar to Navega Therapeutics include Latigo Biotherapeutics, Regenxbio, Regel Therapeutics and Opsin Biotherapeutics.

When was Navega Therapeutics founded?

Navega Therapeutics was founded in 2018.

Where is Navega Therapeutics' headquarters located?

Navega Therapeutics' headquarters is located in San Diego, CA, US.

When was Navega Therapeutics' last funding round?

Navega Therapeutics' most recent funding round was for $1.2M (USD) in April 2022.

How much has Navega Therapeutics raised to-date?

As of Apr 1, 2022, Navega Therapeutics has raised a total of $7.8M (USD).

How many employees does Navega Therapeutics have?

Navega Therapeutics has 10 employees as of Feb 4, 2024.

Navega Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Main Product
  • Gene Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research